• Friday, Jul 10, 2020
  • Last Update : 05:04 pm

Covid-19: WHO set to resume hydroxychloroquine trial

  • Published at 11:57 pm June 3rd, 2020
hydroxychloroquine
File Photo: Researches at the University of Minnesota Genomics Center set up an automated liquid handler as researchers begin a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (Covid-19), at the University of Minnesota in Minneapolis, Minnesota, US on March 19, 2020 Reuters

WHO had paused its large study of the anti-malarial drug to treat Covid-19 due to fears it increased death rates

The World Health Organization (WHO) will resume its trial of hydroxychloroquine for potential use against the novel coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.

The UN agency last month paused the part of its large study of treatments against Covid-19 in which newly enrolled patients were getting the anti-malarial drug to treat Covid-19 due to fears it increased death rates and irregular heartbeats.

The study continued with other medicines.

But the WHO's director-general, Tedros Adhanom Ghebreyesus, said its experts had advised the continuation of all trials including hydroxychloroquine, whose highest-profile backer for use against the coronavirus is US President Donald Trump.

"The executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm of the trial," Tedros told an online media briefing, referring to WHO's initiative to hold clinical tests of potential Covid-19 treatments on some 3,500 patients in 35 countries.

The WHO's decision to suspend its trial prompted others to follow suit, including Sanofi.

A Sanofi spokesman said the company would review available information and run consultations in the coming days to reassess its position following the WHO's latest decision on Wednesday.

The WHO's chief scientist, Soumya Swaminathan, called for other trials of the drug to proceed.

"We owe it to patients to have a definitive answer on whether or not a drug works," she said, adding that safety monitoring should also continue.

Swaminathan said the WHO would be keen to see more results of clinical trials of Avifavir, a drug she said would be used to treat Covid-19 in Russian hospitals "very soon."

In the same virtual briefing, WHO officials said they were especially worried about outbreaks in Latin America and in Haiti, one of the world's poorest nations, where infections have been spreading rapidly.

The coronavirus has infected almost three million people in the Americas and more than 6.43 million worldwide.

60
59
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail